The India emerging infectious disease diagnostics market is projected to experience substantial growth over the forecast period 2023-2033. Moreover, the market value for 2022 was estimated to be $339.1 million and is expected to reach $982.7 million by 2033, showcasing a CAGR of 10.29% during the forecast period.

Market Lifecycle Stage

The India emerging infectious disease diagnostics market is in an emerging phase. Recent years have seen improvements and innovations in diagnostic methods, particularly with the advent of next-generation sequencing and the growing demand for rapid testing (such as in the case of the COVID-19 pandemic). New technologies and devices that offer faster, more efficient, or more cost-effective extraction could rejuvenate the market and push it back toward a growth phase.

Industry Impact

The India emerging infectious disease diagnostics market has proven to be a cornerstone in the evolution of modern biotechnology, clinical diagnostics, and research of different pathogens. Infectious disease diagnostics have a significant impact on various aspects of healthcare and public health. Here are some key impacts:

Accurate and Timely Diagnosis: Infectious disease diagnostics enable healthcare providers to accurately identify the causative agents of infections, leading to timely and appropriate treatment. Early diagnosis helps improve patient outcomes, reduce morbidity and mortality rates, and prevent the spread of infectious diseases.

Effective Patient Management: Diagnostic tests provide critical information for healthcare providers to guide patient management strategies. These tests help determine the most effective treatment options, including the selection of appropriate antimicrobial therapies and the implementation of infection control measures. This leads to better patient care and improved healthcare outcomes.

Public Health Surveillance and Outbreak Control: Infectious disease diagnostics play a crucial role in public health surveillance. By identifying and monitoring infectious agents, diagnostic tests contribute to the detection and tracking of disease outbreaks. This information helps public health authorities implement timely interventions, such as contact tracing, isolation measures, and targeted vaccination campaigns, to control the spread of infections.

Research and Development: Infectious disease diagnostics drive research and development efforts to improve existing diagnostic methods and develop new technologies. Ongoing advancements in diagnostics contribute to the discovery of novel biomarkers, the enhancement of diagnostic accuracy and sensitivity, and the integration of innovative approaches such as molecular techniques, biosensors, and artificial intelligence.

Market Segmentation:

Segmentation 1: by Application
•    Laboratory Testing
•    Point-of-Care Testing

Laboratory Testing to Dominate the India Emerging Infectious Disease Diagnostics Market (by Application)

Based on application, the laboratory testing segment dominated the India emerging infectious disease diagnostics market in FY2022. Laboratory testing plays a crucial role in the diagnosis and management of infectious diseases. It involves the analysis of patient samples, such as blood, urine, sputum, or tissue, to detect the presence of infectious agents. Microbiological culture is a common technique that involves incubating patient samples on specific growth media to isolate and identify bacteria, fungi, or parasites, which can then be visualized through microscopy.

Segmentation 2: by Technology
•    Polymerase Chain Reaction (PCR)
•    Isothermal Nucleic Acid Amplification Technology (INAAT)
•    Next-Generation Sequencing (NGS)
•    Immunodiagnostics
•    Other Technologies

PCR to Dominate the India Emerging Infectious Disease Diagnostics Market (by Technology)

Based on technology, the India emerging infectious disease diagnostics market was dominated by the PCR segment in FY2022. Nowadays, PCR is usually used in several laboratories around the world, as it amplifies DNA further, allowing the analysis of even small amounts of nucleic acid. With growing technological advancements in molecular biology techniques, PCR has been utilized in several fields, including disease diagnosis, DNA profiling, precision medicine, and gene expression.

Next-generation sequencing (NGS) has revolutionized infectious disease diagnosis by enabling comprehensive and high-throughput analysis of pathogen genomes. Whole genome sequencing (WGS) allows the sequencing of entire pathogen genomes, providing detailed information about genetic variations, antimicrobial resistance genes, and virulence factors. It can identify and characterize pathogens, track outbreaks, and analyze their evolutionary patterns.

Other emerging technologies anticipated to register significant growth include technologies such as digital PCR, INAAT, and clustered regularly interspaced short palindromic repeats (CRISPR).
•    Digital PCR is an advanced molecular diagnostic technique used for infectious disease diagnostics. It enables the absolute quantification of target nucleic acids by partitioning the PCR reaction into thousands of individual reactions.
•    INAAT has emerged as a valuable tool for infectious disease diagnostics. INAAT includes technologies such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), which enable rapid and sensitive detection of pathogens without the need for complex equipment or multiple temperature cycles.
•    CRISPR is a relatively new technology, and while it has been leveraged for gene editing and therapeutic purposes ever since the invention of CRISPR/Cas9 gene editing in 2011, it was only in 2016 that CRISPR-Cas systems were first developed to identify nucleic acids for molecular diagnostics.

Segmentation 3: by Type of Infection
•    Bacterial
•    Viral
•    Fungal
•    Other Infections (Parasitic etc)

Bacterial and Viral Segments to Dominate the India Emerging Infectious Disease Diagnostics Market (by Type of Infection)

Based on type of infection, bacterial infectious disease diagnosis involves various methods and techniques to identify the presence of bacterial pathogens in clinical samples. Some of the common bacterial infections include respiratory infections such as tuberculosis and streptococcal infections and sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis.

Viruses have the ability to mutate and, therefore, can lead to the re-emergence of diseases even after one form of the virus has been eradicated or managed. Molecular diagnostic companies are therefore focused on developing tests that can detect a wide range of viruses. Some of the common infections caused by viruses include influenza, genital herpes, COVID-19, hepatitis, mumps, rubella, gastroenteritis, Zika disease, and ebola disease, among others.

Segmentation 4: by Disease Type
•    Respiratory Infections
•    Gastrointestinal Infections
•    Sexually Transmitted Infections (STIs)
•    Neurological Infections
•    Post-Transplant Infections
•    Other Infections

Respiratory Infections to Dominate the India Emerging Infectious Disease Diagnostics Market (by Disease Type)

A vast majority of molecular diagnostic companies offer tests for various kinds of bacteria and viruses responsible for causing respiratory infections. Moreover, the COVID-19 pandemic led to the development of a wide range of tests employing conventional technologies such as reverse transcriptase PCR (RT-PCR) and even leveraging emerging technologies such as RT-LAMP and CRISPR. Several companies now offer multiplex assays that test for influenza A, influenza B, respiratory syncytial virus (RSV), and SARS-CoV-2 virus.

Segmentation 5: by End User
•    Hospitals and Clinics
•    Diagnostic Laboratories
•    Other End Users

Hospitals and Clinics and Diagnostic Laboratories to Dominate the India Emerging Infectious Disease Diagnostics Market (by End User)

Based on end users, the hospitals and clinics and diagnostic laboratories segments accounted for the largest share of the India emerging infectious disease diagnostics market in FY2022. Hospitals and clinics play a critical role in the field of infectious disease diagnostics, serving as important centers for patient evaluation and testing. In addition to point-of-care testing (POCT), which provides immediate results for rapid diagnosis and management, hospitals and clinics may also rely on laboratory testing for comprehensive analysis. Some healthcare facilities have on-site laboratories equipped with state-of-the-art diagnostic technologies, while others collaborate with external diagnostic laboratories for specialized testing. These laboratory facilities employ various methods, including molecular techniques such as PCR and sequencing, serological assays, and culture-based methods to identify and characterize infectious agents accurately.

Recent Developments in the India Emerging Infectious Disease Diagnostics Market

•    In February 2023, Thermo Fisher Scientific Inc. and Mylab announced a pact on test kits for infectious diseases.
•    In February 2023, Biotech startup CrisprBits raised $250,000 in a pre-seed funding round to support the development and commercialization of its CRISPR-based tests.
•    In February 2023, the Food and Drug Administration (FDA) authorized the Xpert Mpox test by Cepheid (parent: DANAHER CORPORATION) for emergency use.
•    In August 2022, Bio-Rad Laboratories, Inc. acquired Curiosity Diagnostics to gain access to PCR ONE, a technology being developed by Curiosity Diagnostics, which can quickly detect a broad range of pathogens.
•    In June 2021, Hologic, Inc. completed the acquisition of Mobidiag to expand its capabilities in molecular diagnostics.
•    In January 2023, CrisprBits developed India’s first CRISPR-based SARS-CoV-2 test with Omicron detection.
•    In March 2023, an India-based startup, Mylab Discovery Solutions Pvt. Ltd., entered into a joint venture with AstraGene LLC, the U.A.E.’s first molecular diagnostics manufacturing company to develop molecular diagnostics in the U.A.E. and Kuwait.
•    In November 2022, Bio-Rad Laboratories, Inc. and NuProbe entered into an exclusive licensing agreement for digital PCR applications.

Demand – Drivers, Restraints, and Opportunities

Market Drivers:

Rising Incidence of Emerging Infectious Diseases in India: The incidence of emerging infectious diseases in India has witnessed a steady rise in recent years, contributing significantly to the expansion of the country’s emerging infectious disease diagnostics market. India emerging infectious disease diagnostics market has experienced substantial growth due to multiple factors. In addition to increased awareness and government initiatives, the country’s past encounters with outbreaks such as Zika, Nipah, and the COVID-19 pandemic have underscored the critical importance of preparedness. As a result, hospitals, laboratories, and healthcare institutions have been channeling resources into advanced diagnostic technologies to detect emerging infectious diseases swiftly and accurately.

Market Restraints:

Inadequate Healthcare Infrastructure and Facilities: The India emerging infectious disease diagnostics market faces significant constraints due to inadequate healthcare infrastructure and facilities. These challenges could have a substantial impact on the ability to effectively diagnose and manage infectious diseases in the country.

For instance, the presence of limited healthcare infrastructure in many parts of India, particularly in rural and remote areas, poses a significant hurdle. These regions often lack well-equipped laboratories and diagnostic facilities, making it difficult to conduct timely and accurate diagnostic tests. As a result, individuals in these underserved areas may not have access to the diagnostics they need, which can lead to delayed diagnoses and increased disease transmission.

Market Opportunities:

Development of Technologically Advanced Platforms in India for Diagnosis: The development of technologically advanced diagnostic platforms in India represents a significant opportunity for players in the emerging infectious disease diagnostics market. The development of advanced diagnostic platforms can help address some of the existing constraints in the healthcare system, such as inadequate healthcare infrastructure and limited access to diagnostics in rural and remote areas.
These advancements include the development of molecular diagnostics, point-of-care testing, immunoassays, and automated systems, among others. These advancements also provide rapid and accurate results, enabling healthcare professionals to make timely treatment decisions.

How can this report add value to an organization?

Workflow/Innovation Strategy: The India emerging infectious disease diagnostics market has been extensively segmented on the basis of various categories, such as application, technology, type of infection, disease type, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: In the India emerging infectious disease diagnostics market product launches, upgradations, and approvals accounted for the maximum number of key developments, i.e., over 75.89% of the total developments in the India emerging infectious disease diagnostics market, as of September 2023.

Competitive Strategy: The India emerging infectious disease diagnostics market is fragmented with several established as well as emerging players. Key players in the India emerging infectious disease diagnostics market analyzed and profiled in the study involve established players that offer various kinds of molecular diagnostic tests for infectious diseases.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

•    The base year considered for the calculation of the market size is 2022. The historical year analysis has been done from FY2020 to FY2021, and the market size has been calculated for FY2022 and projected for the period 2023-2033.
•    The geographical distribution of the market revenue is estimated to be the same as the company’s net revenue distribution. All the numbers are adjusted off to two digits after decimal for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR is calculated from 2023 to 2033.
•    The market has been mapped based on different types of products available in the market and based on several indications. All the key companies that have a significant number of offerings to the India emerging infectious disease diagnostics market have been considered and profiled in the report.
•    In the study, the primary respondent’s verification has been considered to finalize the estimated market for the India emerging infectious disease diagnostics market.
•    The latest annual reports of each market player have been taken into consideration for market revenue calculation.
•    Market strategies and developments of key players have been considered for the calculation of sub-segment split.
•    The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website or from the annual reports of the respective company if stated.

Primary Research

The key data points taken from the primary sources include:

•    Validation and triangulation of all the numbers and graphs
•    Validation of the report’s segmentation and key qualitative findings
•    Understanding of the numbers of the various markets for market type

Secondary Research

Open Sources

•    National Center for Biotechnology Information (NCBI), PubMed, Science Direct, World Bank Group, Organisation for Economic Co-operation and Development (OECD), Centers for Disease Control and Prevention (CDC), Global Burden Disease (GBD), World Health Organization (WHO), and Indian Council of Medical Research (ICMR)
•    Annual reports, SEC filings, and investor presentations of the leading market players
•    Company websites and detailed study of their portfolio
•    Gold standard magazines, journals, whitepapers, press releases, and news articles
•    Databases

The key data points taken from the secondary sources include:

•    Segmentations, split-ups, and percentage shares
•    Data for market value
•    Key industry trends of the top players in the market
•    Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
•    Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Infectious disease diagnostics encompass a range of methods and techniques used to identify and detect infectious agents in individuals suspected of having an infection. These diagnostics play a vital role in timely diagnosis and accuracy, enabling appropriate treatment decisions and public health interventions.

There are two major approaches in the field; one is microbiological culture, which is a fundamental approach in which patient specimens are cultured on specialized growth media to isolate and identify specific pathogens. This technique allows for the determination of the causative organism and the assessment of its antimicrobial susceptibility. Molecular diagnostics, another important approach, utilizes techniques such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs) to detect the genetic material of the infectious agent. This enables highly sensitive and specific identification of pathogens, even at low concentrations.

Some of the prominent companies in this market are:

•    Abbott Laboratories
•    Becton, Dickinson and Company
•    bioMérieux S.A.
•    Bio-Rad Laboratories, Inc.
•    Co-Diagnostics, Inc.
•    DANAHER CORPORATION
•    DiaSorin S.p.A.
•    F. Hoffmann-La Roche Ltd
•    Hologic, Inc.
•    QIAGEN N.V.
•    Thermo Fisher Scientific Inc.
•    Siemens Healthineers AG

Companies that are not a part of the aforementioned pool have been well represented across different sections of the report (wherever applicable).

The post India Emerging Infectious Disease Diagnostics Market: Focus on Epidemiology, Application, Technology, Type of Infection, Disease Type, and End User – Analysis and Forecast, 2023-2033 first appeared on CRI Report.

The global smart irrigation controllers market was valued at $588.47 million in 2021, which is expected to grow with a CAGR of 13.98% and reach $1,280.81 million by 2027.

The growth in the global smart irrigation controllers market is expected to be driven by the increasing adoption of smart agriculture practices and government initiatives toward sustainable irrigation techniques.

Market Lifecycle Stage

The smart irrigation controllers market is in the introductory growth phase. Increased research and development activities in agriculture, rising awareness of tech-based farming, climatic change, and water scarcity in many countries are expected to increase the demand for smart irrigation controllers among the farmers and agriculture companies.

Data management of farms with the help of big data and advancements in communication technologies are some of the major opportunities in the global smart irrigation controllers market. Moreover, the smart irrigation controllers market has huge opportunities in the Asia-Pacific region since most of the countries located in this region have huge agricultural sectors that contribute to each of the nations’ GDP.

Impact

• North America generated the highest revenue of $211.85 million in 2021, which is expected to reach $440.40 million by 2027. The region has been experiencing rapid growth in the smart irrigation industry in the past few years owing to the increasing technological advancements and increasing government support for the use of smart irrigation controllers. Most of the water used for landscape irrigation is wasted because of the use of traditional irrigation systems. Increasing demand for smart irrigation controllers that meet the demand for run times and water schedules automatically is expected to increase the growth in the coming years.
• Furthermore, Europe generated a revenue of $117.69 million in 2021 and is expected to grow at a CAGR of 12.95% from 2022 to 2027. High revenue generation was majorly attributed to increasing the use of smart irrigation systems and increasing investments from the European Commission for IoT-based smart irrigation. Most of the growth is expected to be driven by Eastern Europe countries in the forecast period.

Impact of COVID-19

The COVID-19 impact on the smart irrigation market was witnessed in the short term in 2020 and in 2021. However, the market is anticipated to witness robust growth and recovery with increasing demand for installation of the IoT devices in the agricultural farms throughout the world to make optimum utilization of resources with limited labor requirements in the agriculture fields. Therefore, the demand for smart irrigation controllers in agri and non-agri sectors is expected to increase during and post-COVID-19 pandemic.

Market Segmentation:

Segmentation 1: by Application
• Agriculture
• Non-Agriculture

The global smart irrigation controllers market, based on the application segment, is expected to be dominated by the non-agriculture industry. This is due to the increasing usage of smart irrigation controllers in golf courses, sports grounds, residential areas, private lawns, and gardens.

Segmentation 2: by Type
• Soil-Based Controller
• Weather-Based Controller

The smart irrigation controllers market (by type) is dominated by weather-based irrigation controllers followed by soil-based irrigation controllers. Soil-based irrigation controllers are expected to witness the highest CAGR of 15.18% during the forecast period because sensors installed help in getting real-time soil moisture data at a faster rate depending upon the irrigation requirements. Soil-based controllers are better than weather-based controllers because they do not depend on weather forecasts or the data from the weather stations.

Segmentation 3: by Region
• North America – U.S., Canada, and Mexico
• Europe – Germany, Netherlands, Spain, France, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific – Japan, India, Australia and New Zealand, and Rest-of-Asia-Pacific
• South America – Brazil, Argentina, and Rest-of-South America
• Middle East and Africa – South Africa, Israel, and Rest-of-Middle East and Africa

The Asia-Pacific region is the fastest-growing market in the smart irrigation controllers industry. The rapid change in the climatic conditions, increasing government support, and increasing the need for saving water are the factors supporting the growth of smart irrigation controllers in the region.

Recent Developments in Global Smart Irrigation Controllers Market

• In February 2022, Calsense launched Irrigation Management in terms of a Service, or IMaaS. IMaaS basically represents a unique also highly valuable approach to irrigation management, where it eliminates the need for customers mainly to secure capital funds to buy smart irrigation controllers, sensors as well as software.
• In May 2021, the Toro Company acquired Left Hand Robotics, Inc. The acquisition mainly supports the Toro Company’s strategic leadership in next-generation technologies, which include alternative power, smart connected, as well as autonomous products.
• In March 2020, Netafim had a collaboration with FluroSat to integrate FluroSat’s remote sensing technology into Netafim’s digital irrigation management platform Netbeat.
• In June 2019, Rain Bird partnered with Living Turf as a primary distributor for the full range of Rain Bird Gold Irrigation products throughout Australia. This partnership would enable Rain Bird to expand in Australia.

Demand – Drivers and Limitations

Following are the demand drivers for the smart irrigation controllers market:

• Increasing Adoption of Smart Agriculture Practice
• Increasing Need for Water Conservation
• Increased Government Initiative to Promote Sustainable Irrigation Technique

The market is expected to face some limitations too due to the following challenges:

• High Cost of Smart Irrigation Systems
• Lack of Standardization
• Lack of Technical Knowledge and Limited Awareness among Farmers

How can this report add value?

Product/Innovation Strategy: The product segment helps the reader understand the different types of smart irrigation controller products available to be used in agriculture and non-agricultural fields. Moreover, the study provides the reader with a detailed understanding of the different smart irrigation controllers-based products by application (agriculture-based smart irrigation controllers and non-agriculture-based smart irrigation controllers) and by type (soil-based controllers and weather-based controllers). Smart irrigation controllers reduce outdoor water usage by monitoring and controlling the information about the site and then apply the required amount of water. Smart irrigation controllers are a new generation of irrigation controllers which use the weather conditions, current and historic evapotranspiration, soil moisture levels, and other factors to meet the water demand with regard to plants.

Growth/Marketing Strategy: The global smart irrigation controllers market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been product launches to strengthen their position in the smart irrigation controllers market. For instance, in February 2022, Calsense launched Irrigation Management in terms of a Service, or IMaaS. IMaaS basically represents a unique also highly valuable approach to irrigation management, where it eliminates the need for customers mainly to secure capital funds to buy smart irrigation controllers, sensors as well as software.

Competitive Strategy: Key players in the global smart irrigation controllers market analyzed and profiled in the study involve smart irrigation controller manufacturers that provide different types of smart controllers for several uses. Moreover, a detailed competitive benchmarking of the players operating in the global smart irrigation controllers market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

• Calsense
• Galcon Ltd.
• Holman Industries
• Hunter Industries
• HydroPoint Data Systems, Inc.
• K-Rain Manufacturing Corporation
• Lindsay Corporation
• Nelson Irrigation Corporation
• Netafim
• Rachio, Inc.
• Rain Bird Corporation
• Skydrop
• The Toro Company
• Valmont Industries, Inc.
• Weathermatic

The post Smart Irrigation Controllers Market – A Global and Regional Analysis: Focus on Product and Application, Supply Chain Analysis, and Country Analysis – Analysis and Forecast, 2022-2027 first appeared on CRI Report.

Market Segmentation

• Application – Skin and Sun Care, Hair Care, Make-Up and Color Cosmetics, Fragrances, and Others
• Active Ingredients – Vitamins and Derivatives, Ceramides, Peptides, Resveratrol, Potassium Sorbate, Bio-Succinic Acid, Hyaluronic Acid, Glycerin, Creatine, Alpha Hydroxy Acids, and Others

Regional Segmentation

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Italy, Spain, and Rest-of-Europe
• U.K.
• China
• Asia-Pacific – Japan, South Korea, India, and Rest-of-Asia-Pacific
• Rest-of-the-World – South America and Middle East and Africa

Market Growth Drivers

• Increasing Awareness Regarding Ill-Effects of Synthetic Chemicals
• Government Regulations Restricting the Use of Harmful/Synthetic Ingredients in Cosmetics and Personal Care Products
• Influence of Advertising Strategies on Consumer Trust

Market Challenges

• High Cost of Bio-Based Cosmetic Products
• Concerns Toward the Efficacy of Bio-Based Products as Opposed to Synthetic-Based Cosmetics

Market Opportunities

• Robust Demand for Bio-Based Ingredients Providing Opportunities For Potential Suppliers in Developing Countries
• Increasing Traction of Male-Specific Products

Key Companies Profiled

BASF SE, Covestro AG, DSM, Clariant, DOW, Dynamic Blending Specialists, Croda International Plc, Evonik Industries AG, Elementis Plc, Corbion N.V., Alternative Plants Ltd., Ashland, Solvay, Momentive, The Lubrizol Corporation

How This Report Can Add Value

This report will help with the following objectives:

• A dedicated section focusing on the futuristic trends adopted by key players operating in the global bio-based cosmetics and personal care ingredients market
• Extensive competitive benchmarking of top 15 players (including producers and component providers) offering a holistic view of the global bio-based cosmetics and personal care ingredients landscape
• Qualitative and quantitative analysis of bio-based cosmetics and personal care ingredients industry at region level granularity based on application and active ingredients segments

Product/Innovation Strategy: The product segment helps the reader in understanding different types of active ingredients (vitamins and derivatives, ceramides, peptides, resveratrol, potassium sorbate, bio-succinic acid, hyaluronic acid, glycerine, creatine, alpha hydroxy acids, and others) used in bio-based cosmetic products. The report also includes a thorough qualitative and quantitative analysis of various application areas such as skin and sun care, hair care, make-up and color cosmetics, fragrances, others. Additionally, the research also covers regional and country-wise analysis for different applications and active ingredients in the bio-based cosmetics and personal care ingredients market.

Recent Developments in Bio-Based Cosmetics and Personal Care Ingredients Market

• In May 2021, BASF SE and Allied Carbon Solutions Co., Ltd. signed an agreement to expand the market capacity of bio-based surfactants and active ingredients.
• In October 2021, Ashland launched a new line of gentle deodorant with the brand name Sensidin, a pure skin multifunctional that provides powerful and fast efficacy against odor-causing bacteria at very low use concentrations while respecting the individual microbiome.
• In October 2021, Evonik Industries AG acquired the Swiss plant extract producer Botanica for enhancing its entire product portfolio in the active cosmetic ingredients market.
• In December 2021, Elementis Plc signed a new distribution agreement with DKSH Partner to provide personal care products in Belgium, including antiperspirant actives.

Key Questions Answered in the Report

• What are the major factors and trends impacting the global bio-based cosmetics and personal care ingredients market, and how has the COVID-19 affected the market?
• What are the steps taken by the existing players to improve their market positioning?
• Which are the leading applications in the market, and how are they expected to perform in the coming years?
• What are the latest developments across the globe with respect to R&D, and what would be the trending technology used in the bio-based cosmetics and personal care ingredients market?
• What are the consumption patterns of bio-based cosmetics and personal care ingredients across different regions and countries? Moreover, is there any government regulation across the globe impacting the bio-based cosmetics and personal care ingredients market?
• How do the bio-based ingredients compare to the incumbent synthetic ingredients?

Bio-Based Cosmetics and Personal Care Ingredients

The ingredients obtained from plants and genetically modified microorganisms, such as yeast and bacteria, are bio-based. The bio-based ingredients consist of oleoresin, essential oils, and several other plant extracts using various techniques such as cold pressing or compression, steam distillation, and solvent extraction.

The consumer demand for natural and bio-based products derived from plant extracts has resulted in the rapid growth of the bio-based cosmetics and personal care ingredients market. The primary factor for the increasing adoption of bio-based ingredients for cosmetic products is the harmful effects of chemical products. This has further led to consumers showcasing an inclination toward products that contain bio-based ingredients. As a result, cosmetics companies are consequently substituting synthetic chemicals with bio-based ingredients. Bio-based cosmetics products provide a sustainable alternative to petroleum-based products and help lessen the amount of carbon dioxide in the atmosphere.

Bio-Based Cosmetics and Personal Care Ingredients Industry Overview

The global bio-based cosmetics and personal care ingredients market was estimated at $4,679.33 million in 2021 and is expected to reach $8,122.74 million by 2031, growing at a CAGR of 5.67% during the forecast period 2021-2031.

Market Segmentation

Bio-Based Cosmetics and Personal Care Ingredients Market by Application

The skin and sun care segment is expected to lead the global bio-based cosmetics and personal care ingredients market during the forecast period 2021-2031.
The global adoption of bio-based ingredients for skin and sun care cosmetic products has been the maximum due to the growing demand for clean label beauty products and the increasing health-consciousness among consumers.

Bio-Based Cosmetics and Personal Care Ingredients Market by Active Ingredients

The vitamins and derivatives segment is expected to lead the global bio-based cosmetics and personal care ingredients market during the forecast period 2021-2031. Changing lifestyles and widespread consciousness related to enhancing the overall personality among consumers are expected to drive the global vitamins and derivatives market.

Bio-Based Cosmetics and Personal Care Ingredients Market by Region

North America and Europe hold significant shares in the global bio-based cosmetics and personal care ingredients market. North America is currently the largest revenue-generating region in the bio-based cosmetics and personal care ingredients market. The U.S. is the leading country in the bio-based cosmetics and personal care ingredients market in the North America region.

Europe is the second-largest market globally mainly due to the growing effects of pollution, such as the risk of skin cancer, premature skin aging, dryness, roughness, and discoloration, which push consumers toward protecting their skin using chemical-free products.

Asia-Pacific is currently the fastest-growing region in the bio-based cosmetics and personal care ingredients market.

Key Market Players and Competition Synopsis

The companies that are profiled in the report have been selected based on a selective pool of players, primarily Tier-1 (holding 50-60% of the market) and mid-segment players (comprising 30-40% share), and small and emerging companies (holding the balance 10-20% share), based on various factors such as product portfolios, annual revenues, market penetrations, research, and development initiatives, along with a domestic and international presence in the bio-based cosmetics and personal care ingredients industry.

The key players profiled in the report include BASF SE, Covestro AG, DSM, Clariant, DOW, Dynamic Blending Specialists, Croda International Plc, Evonik Industries AG, ELEMENTIS PLC, CORBION N.V., Alternative Plants Ltd., Ashland, Solvay, Momentive, and The Lubrizol Corporation.

Related Reports: Organic Personal Care Products Market: Market Segments: By Product (Skin Care, Hair Care, Oral Care, Cosmetics and Others); By Distribution Channel (Hypermarket/Supermarkets, Specialist Retail Stores, Online Retail Stores and Others); and Region – 2Global Analysis by Market Size, Share & Trends for 2014 – 22019 and Forecasts to 2030

Related Reports: Starch Derivatives Market: By Product (Maltodextrin, Cyclodextrin, Glucose Syrups, Hydrolysates, Modified Starch, and others); By Raw Material (Corn, Wheat, Cassava, Potato, and Other); By Application (Food and Beverage, Feed, Paper Industry, Pharmaceutical Industry, Bioethanol, Cosmetics and Other); and Region – 2Global Analysis by Market Size, Share & Trends for 2014 – 22020 and Forecasts to 2030

Related Reports: Global Children’s Cosmetics Market Research Report – Forecast till 2026

The post Bio-Based Cosmetics and Personal Care Ingredients Market – A Global and Regional Analysis: Focus on Application, Active Ingredients, and Country-Wise Analysis – Analysis and Forecast, 2021-2031 first appeared on CRI Report.

Market Segmentation

• By Product – Faslodex, RAD1901, GDC-9545, AZD9833, SAR439859, Other Generics
• By Application – First-line treatment and second-line treatment

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, U.K., Italy, Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, and Rest-of-Asia-Pacific (RoAPAC)
• Rest-of-the-World

Growth Drivers

• Rising incidence of breast cancer
• Advanced route of administration: oral drug delivery

Market Challenges

• Resistance to endocrine therapy

Market Opportunities

• SERDs as combination therapy
• Therapeutic potential in different types of cancer

Key Companies Profiled

AstraZeneca, Plc, Novartis AG, Sanofi S.A, Hofmann-la Roche AG, G1 Therapeutics, Zentalis Pharmaceuticals, Zenopharm LLC, Radius Health, Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd, InventisBio, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, HBT Labs, and Amneal pharmaceuticals, Inc.

Key Questions Answered in this Report:

• What is SERD therapy?
• How did the SERD therapy market evolve, and what is its scope in the future?
• What are the major market drivers, restraints, and opportunities in the global SERD therapeutics market?
• What are the key developmental strategies that are being implemented by the key players to sustain this market?
• What is the impact of generics on branded therapy?
• What is the impact of COVID-19 on this market?
• What are the guidelines implemented by different government bodies to regulate the approval of products to be used in breast cancer treatment?
• How is SERD therapy being utilized for the treatment of postmenopausal women with breast cancer?
• What was the market size of the leading segments and sub-segments of the global SERD therapeutics market in 2019?
• How will the industry evolve during the forecast period 2020-2030?
• What will be the growth rate of the SERD therapeutics market during the forecast period?
• How will each segment of the global SERD therapeutics market grow during the forecast period, and what will be the revenue generated by each segment by the end of 2030?
• Which product segment and application segment are expected to register the highest CAGR for the global SERD therapeutics market?
• What is the market size of the SERD therapeutics market in different countries of the world?
• Which geographical region is expected to contribute to the highest sales in the global SERD therapeutics market?
• What is the regulatory framework for the SERD therapeutics market in different regions?
• What are the key strategies incorporated by the players of the global SERD therapeutics market to sustain the competition and retain their supremacy?

Market Overview

The unmet clinical benefits and quest for novel therapies with better efficacy and safety to improve the quality of life in patients living with breast cancer treatment, complete estrogen receptor inhibition, and resistance to multiple endocrine therapies led to the discovery of SERD therapies. SERD therapy has been extensively accepted and used as both monotherapy and in combination with other therapeutic agents. The potential of SERD therapy in breast cancer treatment is yet to be fully discovered, thus leaving a substantial scope of innovation and research in the field.

The global SERD therapeutics market was valued at $1000.2 million in 2019 and is expected to reach $4085.0 million by 2030, witnessing a CAGR of 16.66% during the forecast period 2020-2030. The market growth can mainly be attributed to the increasing breast cancer incidence and mortality worldwide, increasing number of relapsed or refractory cases in breast cancer, unmet clinical benefits with existing breast cancer treatments targeting hormone receptor-positive metastatic breast cancer, eased route of administration and dosage exposure, rising focus of the key players on research and development (R&D) activity for new product launch, and increased government and private funding for improved safety and outcomes provided by SERD therapy.

The global SERD therapeutics market is expected to witness high growth in the future. The increasing global breast cancer incidence and mortality and increased demand for endocrine therapies that cure chronic conditions completely and improve the quality of life of patients are the major factors anticipated to contribute to the growth of the global SERD therapeutics market.

Furthermore, the increasing number of relapsed or refractory cases in breast cancer, unmet clinical benefits with existing breast cancer treatments targeting hormone receptor-positive metastatic breast cancer, painful route of administration and limited dosage exposure will augment the SERD therapeutics market. Also, the increased use of SERDs as combination therapy with other endocrine agents and rising focus of the key players on research and development (R&D) activity for new product launch is expected to drive the market. Rise in government and private funding for improved safety and outcomes provided by SERD therapy are additional factors propelling the growth.

Within the research report, the market is segmented based on therapy type, product, region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The global SERD therapeutics market is currently dominated by Sandoz, Mylan N.V., Glenmark Pharmaceuticals, Dr. Reddy’s Laboratories, Accord Healthcare, and Teva Pharmaceuticals Industries Ltd. The market dominance of these companies can be attributed to cost-effective generic fulvestrant availability in the market. As of 2018, AstraZeneca Plc was the only company to offer SERD therapy in the global SERD therapeutics market. The company has now witnessed a sharp decline after generic launch in several regions. With the pipeline of SERD therapeutics, the market is expected to augment tremendously. Some of the major companies with strong and early pipeline include Sanofi S.A., Hoffmann-La Roche AG, Radius Health, and AstraZeneca Plc.

Based on region, North America is the leading contributor to the SERD therapeutics market in terms of revenue. The growing breast cancer incidence, relapse from existing endocrine therapies, and the substantial research and development made in the field are consequentially promoting the growth of the North America SERD therapeutics market. Also, the Asia-Pacific and Europe regions are expected to register the high CAGR during the forecast period of 2020-2030.

The post Global SERD Therapeutics Market: Focus on Product, Therapy, Country Data (14 Countries), and Competitive Landscape – Analysis and Forecast, 2019-2030 first appeared on CRI Report.

Market Segmentation

• Applications: commercial and passenger vehicle
• Product: tires (connected tires and intelligent tires) and sensors (TPMS, RFID, strain gauge, accelerometer, and others)
• Region: North America, South America, Europe, China, U.K., Middle East and Africa, and Asia-Pacific and Japan

Regional Segmentation

• North America: U.S., Canada, and Mexico
• South America
• Europe: France, Germany, Spain, and Rest-of-Europe
• Asia-Pacific and Japan (APJ) – Japan, India, South Korea, and Rest-of-Asia-Pacific and Japan
• China
• U.K.
• Middle East and Africa

Market Growth Drivers

• Increasing Concerns Regarding Environment and Vehicle Safety
• Rising Adoption of 5G Technology in Smart Tires
• Advancements in Fleet Management Solutions Through Smart Tires
• Usage of Smart Tires in Platooning Systems

Market Challenges

• Lack of Standardization and Commercialization of Smart Tires
• Reliability Issues Faced by Smart Tire Sensors
• Lower Adoption Rate of Automotive Smart Tires in Passenger Vehicles

Market Opportunities

• Surging Demand for Autonomous Vehicles and Highly Automated Driving
• Use of Intelligent Tires in Platooning Systems
• Implementation of 3D Printing Techniques for Automotive Smart Tires

Key Companies Profiled

Continental AG, Bridgestone Corporation, Michelin, The Goodyear Tire & Rubber Co., Pirelli & C. S.p.A, The Yokohama Rubber Company, Limited, Hankook Tire & Technology Co., Ltd., Nokian Tyres Plc., Toyo Tire Corporation, Sumitomo Rubber Industries, Ltd., JK Tyres & Industries Ltd., Revvo Technologies, Inc., NXP Semiconductors, Schrader TPMS Solutions, Infineon Technologies AG

How This Report Can Add Value

Business and Corporate Strategies: The automotive smart tire market is poised to grow over time, compelling companies to come up with collaborative strategies in order to sustain themselves in the intensely competitive market. Companies with identical product portfolios, with a need for additional resources, often partner and come together for joint venture programs, which helps them gain access to one another’s resources and facilitates them to achieve their objectives faster. Furthermore, such ventures result in companies making use of each other’s expertise. Additionally, tire manufacturers have turned toward collaborating with Internet of Things (IoT) service providers for the rapid development of their automotive smart tires. For instance, in March 2018, Continental and Vodafone partnered to deploy commercial fleets with Conti Connect systems.

Key questions answered in the Report

• Why should existing tire and sensor manufacturers consider venturing into the next-generation smart tire market, and what are the future growth opportunities?
• What are the key trends, market drivers, and opportunities in the market pertaining to automotive smart tires?
• What are the major restraints inhibiting the growth of the global automotive smart tire market?
• What kinds of new strategies are being adopted by the existing market players to expand their market position in demand generating developing and developed countries?
• Which are the promising companies that have obtained financial support to develop their products and markets?
• Which are the key companies in the market to source sensors for integrating them into smart tire products?
• How much revenue each of the segments is expected to record during the forecast period along with the growth percentage? Following are the segments:
o Product offerings, including (smart tires and sensors)
o Application, including passenger and commercial vehicles
o Region, including North America, South America, the U.K., Europe, Asia-Pacific and Japan, China, and the Middle East and Africa
• Which type of players and stakeholders are operating in the market ecosystem of the automotive smart tire, and what is their significance in the global market?

Global Automotive Smart Tire Market

Smart tires are new-generation tires equipped with various sensors and chips for transferring actual data about tire and road conditions to the driver via telematics and Bluetooth in different types of vehicles.

The growing trend of integrating advanced technologies and sensors in a vehicle, along with the increasing need for fleet management and asset tracking, has led to the demand for automotive smart tires. Smart tires constitute intelligent tires and connected tires. Intelligent tires, i.e., those embedded with TPMS sensors, are well known globally. However, there are only limited automotive smart tires that have been made commercially available to the vehicle manufacturers. Major commercial vehicle OEMs and fleet operators are eager to deploy automotive smart tires to enhance their fleet management solutions as well as get real-time tire monitoring for their platoons.

Global Automotive Smart Tire Industry Overview

The global automotive smart tire market is expected to reach $110.39 billion by 2026, with a CAGR of 6.20% from 2021 to 2026. The rapid advancements in the development and commercialization of connected and autonomous vehicles have led to the evolution of technology to develop several automotive components. As the trend to develop these next-generation vehicles is being realized in the industry, the reliance on traditional tires is expected to be replaced by the adoption of smart sensor-enabled tires.

Smart tires are enabling commercial vehicle manufacturers to manage and monitor their fleets through digital monitoring solutions. The increasing volume of commercial vehicles with time has allowed fleet operators to monitor several parameters such as fuel consumption and carbon emissions, leading to an increased demand for advanced tires that provide real-time monitoring of tire conditions.

Market Segmentation

Global Automotive Smart Tire Market by Sensor Type

This segment emphasizes the growth of each product (sensors) for smart tires during the forecast period. The study covers various types of traditional and next-generation sensors such as TPMS, RFID Chip, accelerometer sensors, and strain gauge sensors. Among these, TPMS sensors accounted for the largest market share in 2020 and continue to dominate the market in the given forecast period (2021-2026), driven by strong government and regulatory bodies’ support.

Global Automotive Smart Tire Market by Application

The segment gives a brief overview of the market status of different applications of the product and key players offering products in those applications. Passenger vehicles are one of the major application areas for automotive smart tires. The rapid advancements in the development and commercialization of connected and autonomous vehicles have led to the evolution of technology for several automotive components. As the trend to develop these next-generation vehicles is being realized in the industry, the reliance on traditional tires is expected to be replaced by the adoption of connected and TPMS sensor-enabled tires.

Commercial vehicles include light commercial vehicles (LCVs) such as pick-up trucks, heavy buses, and heavy trucks. Smart tires are enabling commercial vehicle manufacturers to manage and monitor their fleets through digital monitoring solutions.

Key Market Players and Competition Synopsis

Some of the key players operating in the market, include Continental AG, Bridgestone Corporation, Michelin, The Goodyear Tire & Rubber, Pirelli & C. S.p.A, The Yokohama Rubber Company, Limited, Hankook Tire & Technology Co., Ltd., Nokian Tyres Plc., Toyo Tire Corporation, Sumitomo Rubber Industries, Ltd., JK Tyres & Industries Ltd., Revo Technologies, Inc., NXP Semiconductors, Schrader TPMS Solutions, and Infineon Technologies AG.

The segment provides details about the competitive strength of the key players operating in the market. Continental AG and Goodyear Tire & Rubber Company account for the largest market share in the ecosystem, owing to their vast market presence and various partnerships with OEM.

The post Automotive Smart Tire Market – A Global Market and Regional Analysis and Forecast, 2020-2026 first appeared on CRI Report.